Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
2.8%
1w
5.3%
1m
11.1%
3m
11.5%
6m
20.2%
1y
38.0%
5y
17.8%
all
13.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,273 2.8%
1,084
1,490
Company Overview
Sales
2,590 Cr
Growth: 6.8%
Profit after Tax
603 Cr
Growth: 6.8%
Mid Cap
15,628 Cr
P/E: 26.0x
Industry P/E: 32.5x
Fundamentals
Sales (Cr) ₹ 2,590
Growth 6.8%
EBITDA 32.3%
P/S 6.0x
Dividend 0.5%
P/E 26.0x
Book Value ₹ 284
PEG Ratio 3.8x
ROE 18.4%
P/B 4.5x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (11 Indices) view more
Investors (7)
icici.pr...
societe....
santhosh...
Followers (2)
atharav
varsha96